Israeli healthtech DayTwo has raised $12m in a Series A financing round, featuring Johnson & Johnson Innovation-JJDC, the Mayo Clinic, DayTwo Co-founder Marius Nacht and Seventure Partners, to name some. The company is developing an app that will allow users to track their health data on a daily basis, including how much exercise they do, what medications they’re taking, whether they’ve been diagnosed with any chronic disease or The funds will be used to expand the product, as well as add to engineering, and data science teams in Tel Aviv and San Francisco.
Israeli healthtech DayTwo has raised $12m in a Series A financing round, featuring Johnson & Johnson Innovation-JJDC, the Mayo Clinic, DayTwo Co-founder Marius Nacht and Seventure Partners, to name some. DayTwo's app offers users personalised nutrition services, based on the DNA sequencing of a customer's gut bacteria. The funds will be used to expand the product, as well as add to engineering, and data science teams in Tel Aviv and San Francisco.